Casdin Capital as of June 30, 2016
Portfolio Holdings for Casdin Capital
Casdin Capital holds 25 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 8.8 | $8.8M | 294k | 30.13 | |
| Spark Therapeutics | 8.3 | $8.3M | 163k | 51.13 | |
| Agios Pharmaceuticals (AGIO) | 7.8 | $7.9M | 188k | 41.89 | |
| Foundation Medicine | 7.2 | $7.3M | 390k | 18.66 | |
| Global Blood Therapeutics In | 7.1 | $7.1M | 430k | 16.59 | |
| Loxo Oncology | 6.9 | $7.0M | 300k | 23.18 | |
| Blueprint Medicines (BPMC) | 6.8 | $6.9M | 340k | 20.25 | |
| Bluebird Bio | 5.3 | $5.3M | 123k | 43.29 | |
| Evolent Health (EVH) | 4.6 | $4.6M | 240k | 19.20 | |
| Alnylam Pharmaceuticals (ALNY) | 4.0 | $4.0M | 73k | 55.49 | |
| Kite Pharma | 3.6 | $3.6M | 73k | 50.00 | |
| GenMark Diagnostics | 3.6 | $3.6M | 415k | 8.70 | |
| Voyager Therapeutics (VYGR) | 3.5 | $3.5M | 323k | 10.99 | |
| Epizyme | 3.5 | $3.5M | 340k | 10.24 | |
| Cytomx Therapeutics (CTMX) | 2.4 | $2.4M | 234k | 10.21 | |
| Dex (DXCM) | 2.4 | $2.4M | 30k | 79.33 | |
| Myokardia | 2.2 | $2.2M | 179k | 12.40 | |
| Clovis Oncology | 2.0 | $2.1M | 150k | 13.72 | |
| Ignyta | 2.0 | $2.0M | 375k | 5.42 | |
| Avexis | 1.7 | $1.7M | 45k | 38.02 | |
| Tesaro | 1.7 | $1.7M | 20k | 84.05 | |
| SPDR S&P Biotech (XBI) | 1.6 | $1.6M | 30k | 54.07 | |
| Bristol Myers Squibb (BMY) | 1.5 | $1.5M | 21k | 73.57 | |
| Syros Pharmaceuticals | 0.9 | $908k | 50k | 18.16 | |
| Medgenics | 0.5 | $472k | 85k | 5.55 |
